Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

188.60 +6.91 (+3.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Natera to Participate in Upcoming Investor Conferences
From Natera, Inc.
Via Business Wire
Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors
From Natera, Inc.
Via Business Wire
Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call
From Natera, Inc.
Via Business Wire
Why Natera Stock Is Leading Its Industry Group With A 17% Jump Today
Natera snagged a key win that could help extend its patient pool. 
Via Investor's Business Daily
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash. 
Via Benzinga
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancer
From Natera, Inc.
Via Business Wire
New Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Disease
From Natera, Inc.
Via Business Wire
New Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023
From Natera, Inc.
Via Business Wire
Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
 
Via Benzinga
Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer
From Natera, Inc.
Via Business Wire
Natera to Webcast Live Presentation at the 41st Annual J.P. Morgan Healthcare Conference
From Natera, Inc.
Via Business Wire
Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
From Natera, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
Lowe's, Alcon And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Nasdaq dropping more than 180 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Robinhood, MicroStrategy And Other Big Losers From Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Earnings Preview For Natera
Natera (NASDAQ:NTRA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Natera will report an... 
Via Benzinga
Is Illumina Still the Gamechanger in Genomics Sequencing?
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused 
Via MarketBeat
Topics Earnings Economy Lawsuit
NASDAQ:NTRA Long Term Investor Notice: Investigation of Potential Wrongdoing at Natera, Inc.
San Diego, CA -- (SBWIRE) -- 09/02/2022 -- Certain directors of Natera, Inc are under investigation concerning potential breaches of fiduciary duties. 
Via SBWire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Natera, Inc. (NTRA) Investors of Class Action and Encourages Investors to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
NATERA 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Natera, Inc. - NTRA
From Kahn Swick & Foti, LLC
Via Business Wire
NATERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Natera, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Natera, Inc. (NTRA)
From The Law Offices of Frank R. Cruz
Via Business Wire
NASDAQ:NTRA Investor Alert: Deadline on June 27, 2022 in Lawsuit Against Natera, Inc.
San Diego, CA -- (SBWIRE) -- 06/22/2022 -- The Shareholders Foundation announced that a deadline is coming up on June 27, 2022 in the lawsuit filed for certain investors of Natera, Inc. (NASDAQ:NTRA). 
Via SBWire
Tackling Recurring Health Conditions Offers Hope to Patients
Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly... 
Via FinancialNewsMedia
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Upcoming Lead Plaintiff Deadline
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.